Abeona Therapeutics (ABEO) Gross Margin: 2011-2025
Historic Gross Margin for Abeona Therapeutics (ABEO) over the last 14 years, with Sep 2025 value amounting to 100.00%.
- Abeona Therapeutics' Gross Margin changed negligibly% to 100.00% in Q3 2025 from the same period last year, while for Sep 2025 it was 100.00%, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of 100.00% for FY2024, which is 4586.00% up from last year.
- According to the latest figures from Q3 2025, Abeona Therapeutics' Gross Margin is 100.00%, which was down 0.00% from 100.00% recorded in Q2 2025.
- In the past 5 years, Abeona Therapeutics' Gross Margin ranged from a high of 100.00% in Q1 2021 and a low of -47.06% during Q4 2022.
- Over the past 3 years, Abeona Therapeutics' median Gross Margin value was 100.00% (recorded in 2025), while the average stood at 100.00%.
- As far as peak fluctuations go, Abeona Therapeutics' Gross Margin crashed by 14,706bps in 2022, and later spiked by 14,706bps in 2023.
- Over the past 5 years, Abeona Therapeutics' Gross Margin (Quarterly) stood at 100.00% in 2021, then plummeted by 14,706bps to -47.06% in 2022, then surged by 14,706bps to 100.00% in 2023, then remained steady at 100.00% in 2024, then remained steady at 100.00% in 2025.
- Its Gross Margin stands at 100.00% for Q3 2025, versus 100.00% for Q2 2025 and 100.00% for Q1 2025.